Tata Chemicals (TATACHEM) Q2 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 25/26 earnings summary
3 Nov, 2025Executive summary
Global demand for key products remains flat in the near term, with robust demand in India and Asia (excluding China), but weakness in China and Southeast Asia due to oversupply and high inventories.
Medium- to long-term outlook is positive, driven by solar PV and EV growth, despite short-term margin challenges and ongoing geopolitical and tariff risks.
Board approved unaudited consolidated and audited standalone financial results for Q2 and H1 FY2026, with results published and available online.
Board approved fund raising via non-convertible debentures (NCDs) up to ₹1,500 crore on a private placement basis.
Higher sales volumes in India were offset by lower realizations across all geographies, impacting profitability.
Financial highlights
Standalone revenue from operations increased 19% year-over-year; EBITDA rose 67%; profit after tax up 80%.
Consolidated revenue for Q2 FY2026 was ₹3,877 crore, down from ₹3,999 crore in Q2 FY2025; H1 FY2026 revenue was ₹7,596 crore, down from ₹7,788 crore in H1 FY2025.
Q2 FY2026 EBITDA margin was 14%, down from 15% in Q2 FY25; PAT margin was 6%, compared to 7% in Q2 FY25.
Net profit for Q2 FY2026 stood at ₹154 crore, compared to ₹267 crore in Q2 FY2025.
Net debt increased to ₹5,583 crore as of Sep 2025 from ₹4,884 crore in Mar 2025.
Outlook and guidance
Soda ash prices expected to remain subdued and range-bound for the rest of the year due to oversupply and high Chinese inventories.
U.K. operations expected to turn positive in Q3 and Q4 as reconfiguration completes and focus shifts to value-added products.
Indian margins expected to stabilize, with volumes tracking higher and anti-dumping measures providing some price support.
Medium-term market normalization anticipated as global capacity reconfiguration progresses and tariff frictions ease.
Board authorized an internal committee to finalize terms for the NCD issuance, indicating a focus on strengthening liquidity and funding future growth.
Latest events from Tata Chemicals
- Revenue and profit fell on low prices and UK closure; net debt and risks increased.TATACHEM
Q3 24/253 Feb 2026 - Sequential revenue and EBITDA growth, but year-over-year declines amid European market headwinds.TATACHEM
Q1 24/252 Feb 2026 - Earnings fell on weak soda ash prices and plant closure, but India and Kenya volumes grew.TATACHEM
Q3 25/262 Feb 2026 - Q2 FY25 revenue ₹3,999 crore, net profit ₹267 crore, expansions ramping up post-rains.TATACHEM
Q2 24/2519 Jan 2026 - FY25 net loss from UK impairments; revenue and margins fell, dividend of ₹11.00 proposed.TATACHEM
Q4 24/2524 Nov 2025 - Q1 FY26 saw higher profit and margins despite flat demand and global oversupply.TATACHEM
Q1 25/2625 Jul 2025